Vol. 84, Issue 3, 1088-1095, March 1998
MODELING IN PHYSIOLOGY
Role of metabolic gases in bubble formation during hypobaric
exposures
Philip P.
Foster1,
Johnny
Conkin1,
Michael
R.
Powell2,
James M.
Waligora2, and
Raj S.
Chhikara3
1 Universities Space Research Association,
Division of Space Life Sciences, 2 Environmental
Physiology Laboratory, Life Sciences Research Laboratories, National
Aeronautics and Space Administration Johnson Space Center, and
3 Division of Computing and Mathematics,
University of Houston
Clear Lake, Houston, Texas,
77058
 |
ABSTRACT |
Our hypothesis is that metabolic gases
play a role in the initial explosive growth phase of bubble formation
during hypobaric exposures. Models that account for optimal internal
tensions of dissolved gases to predict the probability of occurrence of
venous gas emboli were statistically fitted to 426 hypobaric exposures from National Aeronautics and Space Administration tests. The presence
of venous gas emboli in the pulmonary artery was detected with an
ultrasound Doppler detector. The model fit and parameter estimation
were done by using the statistical method of maximum likelihood. The
analysis results were as follows. 1) For the model without an
input of noninert dissolved gas tissue tension, the log likelihood (in
absolute value) was 255.01. 2) When an additional parameter was
added to the model to account for the dissolved noninert gas tissue
tension, the log likelihood was 251.70. The significance of the
additional parameter was established based on the likelihood ratio test
(P < 0.012). 3) The parameter estimate for the
dissolved noninert gas tissue tension participating in bubble formation
was 19.1 kPa (143 mmHg). 4) The additional gas tissue tension,
supposedly due to noninert gases, did not show an exponential decay as
a function of time during denitrogenation, but it remained constant.
5) The positive sign for this parameter term in the model is
characteristic of an outward radial pressure of gases in the bubble.
This analysis suggests that dissolved gases other than N2
in tissues may facilitate the initial explosive bubble-growth phase.
bubble growth; Doppler ultrasound; inert and noninert dissolved
gases; tissue ratio; logistic model; log likelihood; gas kinetics
 |
INTRODUCTION |
REDUCTION IN AMBIENT PRESSURE is experienced by divers,
aviators, and astronauts. The Shuttle and the Russian Space Station Mir
atmospheres are at a pressure of 101.3 kPa, but astronauts or
cosmonauts are exposed to a reduced absolute pressure in the space suit
when they are performing extravehicular activity (EVA). Decompression
may lead to the formation and growth of gas bubbles within tissues (3,
4, 16), with a resultant risk of decompression illness (DCI). In
humans, the composition of gas bubbles in tissues is not amenable to
direct experimental verification. Furthermore, analysis of
intravascular bubbles does not provide information about the fractions
of dissolved gas in tissues participating in bubble formation (8).
O2 and CO2 rapidly permeate in and out of the
bubbles, compared with N2 (13). After sufficient time, the
gas in bubbles presumably equilibrates with metabolic levels of
O2 and CO2 in mixed venous blood or tissue, and
with the body saturation level for water vapor pressure (8, 13). In
contrast to hyperbaric decompressions, metabolic gases form a large
fraction of the gas in bubbles during hypobaric decompressions (15).
Moreover, theoretical simulations utilizing a system of mathematical
equations (13) suggested a significant role for metabolic gases in
bubbles during hypobaric decompressions.
Our hypothesis is that metabolic gases are involved in the initial
growth phase of bubbles. An analysis is made by using experimental results from human exposures conducted in altitude chambers that simulate EVA procedures. Oftentimes, venous gas emboli (VGE) can be
detected in the venous blood flow (7, 9) when a Doppler ultrasound
bubble detector is used. Bubbles spawned in capillaries of tissues were
mobilized into the venous return by flexing the limb during the period
of bubble monitoring. Models that account for the tensions of dissolved
gases in tissues and predict VGE incidence were statistically fitted to
the data. We evaluated whether the incorporation of an additional
mechanistic parameter into a model produced a better fit to the
observed response. The model with the best fit to the data is assumed
to support the more realistic hypothesis.
 |
METHODS |
Glossary
| FIO2 |
Fraction of inspired O2, dimensionless
|
| FIN2 |
Fraction of inspired N2, dimensionless
|
| i |
Subscript for the ith record (426 records)
|
| L |
Likelihood function, dimensionless
|
| LL |
Natural logarithm of the likelihood function, dimensionless
|
| PACO2 |
Alveolar CO2 partial pressure of 5.33 kPa (40 mmHg)
|
| PAH2O |
Alveolar H2O pressure of 6.27 kPa (47 mmHg)
|
| PAN2 |
Alveolar N2 partial pressure, kPa
|
| PaN2 |
Arterial N2 tension, kPa
|
| PAO2 |
Alveolar O2 partial pressure, kPa
|
| PB |
Total absolute pressure of the breathing medium; pressure at altitude,
kPa
|
| Pother |
Additional dissolved gas tissue tension, kPa
|
| P |
Probability of occurrence of VGE, dimensionless
|
| PtiN2(0) |
Initial N2 tissue tension just before the procedure of
interest, kPa
|
| PtiN2(t) |
Dissolved N2 tissue tension at a time t; estimated
dissolved N2 tissue tension at the end of denitrogenation,
kPa
|
| R |
Respiratory exchange ratio,
CO2/ O2,
dimensionless
|
| t1/2 |
Tissue half time for washin and washout of N2, min
|
| t |
Time of interest, usually the end of the O2
prebreathing, min
|
CO2 |
Amount of CO2 eliminated, l/min
|
O2 |
Rate of O2 uptake, l/min
|
| yi |
VGE outcome, 1 if VGE occurred, or 0 if none, dimensionless
|
Estimation of Dissolved N2 Tension in Tissues
The PAN2 determines the
PaN2, and this in turn defines the
dissolved N2 tension in the tissues. The
denitrogenation, or N2 "washout" during the
prebreathe procedure, consists of breathing an O2-enriched
breathing medium (2); this can be pure O2 or an
O2-N2 mixture with different inspired fractions
of O2 and N2, denoted by
FIO2 and
FIN2, respectively. The
PAO2 is calculated by using the
alveolar gas equation (10). The
PAN2 equals the total ambient
pressure PB of the breathing medium minus
PACO2, PAO2, and
PAH2O. In accordance with
Dalton's law, the PAN2 can be
expressed as follows
|
(Eq. 1)
|
where alveolar partial pressures of gases
(PAO2,
PACO2, and
PAN2) are under body conditions of
temperature, ambient pressure, and saturation with water vapor
(BTPS). Arterial O2, CO2, and N2 tensions (PaO2,
PaCO2, and PaN2,
respectively) are assumed to be equal to their alveolar partial
pressures (e.g.,
PaN2 = PAN2). To determine the influence of the respiratory exchange ratio R, we
statistically optimized the value of R in the physiological range between 0.7 and 1.0.
Assuming a perfusion-limited system (2-4), an approximation of the
N2 partial tension of dissolved inert gas in the tissue during any N2 partial pressure change in the breathing
medium is provided by the classic exponential model
|
(Eq. 2)
|
where ln (2) is the natural logarithm of 2 and
t is the elapsed O2 prebreathe time. The dissolved
N2 tissue tension at the end of each denitrogenation stage
was estimated by using iterations with Eq. 2 for each National
Aeronautics and Space Administration (NASA) pre-EVA denitrogenation.
MATHEMATICA software, version 2.2 (24), was employed for
this purpose. The ascent time for each pressure change was included as
part of the denitrogenation time.
NASA Hypobaric Data Set
Subjects.
There were 164 volunteers (37 women and 127 men), who participated in
426 hypobaric exposures at the Johnson Space Center between 1982 and
1990. The average age was 31.38 ± 7.2 yr. Their individual
characteristics were representative of the astronaut population. Women
were included during the latter part of these studies. All were
required to pass the United States Air Force Class III Flight Physical
examination. The subjects signed an informed consent and were free to
withdraw from the tests at any time.
Test procedures for simulated EVAs.
The chamber tests were not all the same, since 1)
denitrogenation periods varied; 2) the breathing gas during the
denitrogenation was 100% O2 at 101.3 kPa [14.7
lb./in.2 absolute (psia)]; 3) however, some tests
used a staged decompression, a prolonged stay at an atmosphere of 70.3 kPa (10.2 psia) enriched with O2 and with a reduced
N2 partial pressure (26% O2-74%
N2), as part of the denitrogenation process; 4) at
altitude, after the final decompression, the breathing gas was 100%
O2 or O2-N2 mixtures; 5)
the pressure at altitude ranged from 29.64 kPa (4.3 psia) to 44.80 kPa
(6.5 psia); and 6) the time at altitude varied from 3 to 6 h.
In all these tests, no exercise was performed during the O2
prebreathe, and subjects were reclined or seated. Each subject was
exposed to a particular denitrogenation and decompression profile;
several of the same profiles constituted a test. Twenty tests were
conducted. When test groups were separated with respect to gender, the
total number of groups was 23. A low level of exercise during the
simulated EVA involving upper limbs with an average metabolic rate of
837 kJ/h (200 kcal/h) was performed.
Dependent variable.
VGE in the pulmonary artery were detected with a Doppler ultrasound
bubble detector in the precordial position at ~15-min intervals
throughout the exposure. The bubbles were mobilized by flexing the
joints and straining the muscle groups of a limb (1) at the time of
bubble monitoring. It is assumed that we measure the "limb
bubble-formation tendency" before the time of monitoring. We code
the presence of VGE in the pulmonary artery as 1, or 0 if no bubbles
were detected.
Independent variable.
We define a dose for the decompression (2, 14) as tissue ratio (TR),
which is the ratio of the calculated dissolved N2 tissue
tension for a given tissue to the ambient pressure
|
(Eq. 3)
|
where PtiN2(t) is the dissolved
N2 tissue tension at the end of the denitrogenation period,
as obtained from Eq. 2, and PB is the ambient
pressure at altitude. In Eq. 3, TR is expressed by using only
the calculated dissolved N2 tissue tension. A second determination of dose, i.e., TR', is considered to be
|
(Eq. 4)
|
where Pother is the magnitude of dissolved gas tissue
tensions other than N2. The addition of Pother
tests whether dissolved gas tissue tension other than N2
plays a significant role in bubble formation during hypobaric
exposures.
Statistical Analysis
Logistic regression model.
The probability of VGE occurrence is modeled as a function of the
decompression dose, TR or TR'. An appropriate statistical model for the
probability of occurrence of an event is often assumed to be logistic
(6). In terms of a function of dose, the probability P of occurrence of VGE is defined by the logistic
regression equation, namely
|
(Eq. 5)
|
where
0 and
1 are unknown parameters.
The use of a similar probability function for the VGE dose-response
relationship, the Hill equation, is documented elsewhere (2, 17, 20). We rewrote Eq. 5 into a form comparable to the Hill equation
|
(Eq. 6)
|
where b0 =
1 and
b1 = exp (
0/
1)
are two statistical parameters. Moreover, unknown physiological
parameters, t1/2 and Pother, also must
be optimally determined. The three-parameter model with
Pother = 0 thus becomes a four-parameter model when Pother is taken to be a nonzero quantity, and this must be
determined so that it maximizes the likelihood function.
Maximum-likelihood method.
Maximum-likelihood estimation is the preferred technique (3, 4, 11, 14,
20, 22) to estimate unknown parameters in a model so that the
probability function is maximized. Given a set of data, the likelihood
function L is defined as the product of the probability
densities for the subjects' outcomes
|
(Eq. 7)
|
where Pi is the probability and
yi denotes the VGE outcome (1 or 0) for the
ith record; total number of records was 426. It is customary to
use the natural logarithm of the likelihood function
|
(Eq. 8)
|
The log likelihood function,
LL(b0, b1), is
always negative, since ln (Pi) and
ln (1
Pi) are negative as
Pi lies between 0 and 1. The maximum likelihood
estimates of b0 and b1 that
maximize the LL function can be obtained by solving the
following equation
|
(Eq. 9)
|
for the 20 different denitrogenation procedures. We used the
NONLIN module of SYSTAT version 5.03 (23) to
solve Eq. 9 and to estimate unknown parameters in the models
with the sum of absolute values, |LL|,
minimized by using the quasi-Newton algorithm. In what follows, the
absolute value of the LL function will be noted LL. For
simplicity, the lowest LL value will be designated as the
"best" LL value.
The tissue half time was estimated as part of the model by a
trial-and-error method (3, 14) with the use of SYSTAT. The trial-and-error method is comparable with a fully computerized fitting
process. A spectrum of half times from 240 to 700 min was tested
initially at ~20- to 50-min intervals, and then the half times were
progressively decreased to 1-min intervals as the model approached the
best fit to the data.
Test of statistical hypotheses.
The likelihood ratio test statistic (14, 20) is used to assess whether
additional parameters added to a model improve the goodness of fit. The
degrees of freedom of a test statistic are equal to the number of
parameters estimated in a full model minus the number of parameters in
a hypothesized model. The likelihood ratio test statistic is
transformed, from a ratio to a difference, by taking twice the
difference between the two corresponding LL values. The
transformed statistic follows a
2 distribution. Finally,
a
2 table is entered with the calculated likelihood
ratio and the difference in degrees of freedom between the two models
to determine the appropriate P value.
 |
RESULTS |
Table 1 lists the family of models tested,
the fitted parameters in each model, and the LL value obtained
in each case. The three-parameter model with only N2
dissolved tissue tension in the expression of dose defined by Eq. 3 (Pother = 0), resulted in an LL value of
255.01. The ability to describe the response variable improved by
accounting for an additional dissolved gas tissue tension other than
N2 in the dose expression of Eq. 4. The
four-parameter model (Pother
0) returned an
LL of 251.70, the best LL value that we encountered,
indicating that it has the best fit to the data. A decrease of 3.31 LL units by the addition of Pother in dose is
statistically significant at P = 0.012 under the likelihood
ratio test. We also define an upper and lower boundary of the
LL value (14, 20) to further evaluate the goodness of fit of
our best model. The hypothesis that dose of decompression is not useful
in predicting VGE defines the "null" model; it is considered as
an upper boundary. This is a constant-probability model with one
scaling parameter that is estimated by the odds ratio of cases with VGE
vs. no VGE. This model returned a value of 290.46 for LL, which
significantly differs from all the other models tested. The LL
value of 240.08 corresponded to the low-boundary case of the
"discontinuous" model, which consisted of separate null models
for the 23 groups of data. This discontinuous model, of course, is too
data specific to be effective for prediction beyond the range of
observations utilized. The discontinuous model and the four-parameter
model are, however, not statistically different, since the likelihood
ratio test based on the 19 degrees of freedom for the
2
statistics yielded a P value >0.50.
Table 2 lists information for the best fit
four-parameter model shown in Table 1. The estimated value for
Pother was 19.1 kPa (143 mmHg). The asymptotic SE for
Pother was 4.64, which is small, relative to the parameter
estimate. The asymptotic correlation matrix in Table
3 indicates that Pother was
poorly correlated with b0; therefore, it merits
retaining Pother in the model (12). However,
Pother was significantly correlated with
b1, implying that a change in Pother
would have caused large changes in b1. The
estimates of b0 and b1 were
several times larger than their SE values, thus indicating their
significance in the model. The t1/2 had a value of
329 min.
Because t1/2 was estimated from trial-and-error
modification of potential models, the study of these models allows
further insight into relations between t1/2 and
Pother. Close inspection of Fig.
1 shows that the distribution of
isopressure isopleths (LL vs. t1/2, at six
different values of Pother) follows a specific pattern. The
parabolic shape of these isopleths is a property of the maximum
likelihood optimization. As Pother increases in value, the
isopleth becomes steeper. The minimum on the isopleth corresponds to
the best fit of this model with the data. The intercept of the 19.1 isopleth with the 329-min t1/2 corresponds to the best fit model. On the other hand, the t1/2
estimate for the three-parameter model located at the minimum of the 0 kPa isopleth has a value of 420 min. Figure 1 also shows that our best
fit model is robust, since slight variations of Pother,
e.g., within 2 kPa of 19.1 kPa, hardly affect the LL value.
Furthermore, variations of Pother within the range of the
SE (4.64 kPa) do not significantly affect the estimated model.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Plot of six isopressure isopleths on natural logarithm of likelihood
function (LL) vs. half time t1/2
corresponding to six additional dissolved gas tissue tension
(Pother) values of 0, 0.5, 17.7, 19.1, 21.0, or 30.0 kPa.
Three isopleths, 17.7, 19.1, and 21.0 kPa, are almost superimposed;
their LL minima are nearly equal, occurring at the same
t1/2. Because there is no significant difference
among the three cases, the 19.1-kPa isopleth is taken to be the best
fit model with the lower LL number. The 17.7-kPa isopleth
corresponds to the estimates of mixed venous blood (or tissue) tensions
of O2, CO2, and water vapor pressure.
|
|
Another approach to making comparison between models is the graphic
illustration of goodness of fit as shown in Figs. 2 and 3. Each circle represents a
group of subjects, and the size of a circle is proportional to the
corresponding group size; there were 23 groups. For a given group, the
value on the y-axis is the observed incidence of VGE in this
group. The sigmoidal curves show the predicted probability of VGE by
two different models: the best fit four-parameter model (Fig. 2) and a
three-parameter model (Fig. 3). The models were fitted using a NASA
data set consisting of 426 individual observations, as described
earlier. The position of all the circles around the curve provides a
visual impression of the fit; circles close to the sigmoidal curve
indicate a better fit of the model to the data. However, this goodness
of fit criterion based on the examination of group incidence is limited
because of the lack of reliability of the visual interpretation of
observed incidences. Because the model fit takes into account the size of groups of data as weight for each group of subjects, the model represents the larger groups of subjects better than it does the smaller groups. Overall, the best fit model (Fig. 2) does not seem to
over- or underpredict the incidence of VGE, except for a few small
groups of subjects. In contrast, Fig. 3 depicts a poor fit for the
three-parameter model with a 240-min
t1/2, since it did over- and underestimate the VGE
incidence even in larger groups of subjects, and circles are dispersed
away from the model curve. Although the model fit is weighted according
to the size of subject groups, Fig. 3 shows that a model with an
inappropriate t1/2 and absence of
Pother fails to accurately predict the observed incidence,
even in the case of larger groups of subjects.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Display of goodness of fit between our best model and observed
incidence in groups of tests composing the data set. Dose is defined as
tissue ratio (TR') from Eq. 4; parameter estimates were
t1/2 = 329 min, and Pother = 19.1 kPa. Area of a circle is proportional to no. of subjects in a
group; smallest circle has 3 subjects, and largest circle has 59. Estimated probability curve intercepts centers of larger circles (59, 35, and 28 subjects). Three subjects in topmost smallest circle have a
venous gas emboli (VGE) incidence of 1; therefore, model underestimates
the outcome for this group.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Display of goodness of fit of a 3-parameter model with
t1/2 of 240 min; a model with a poor fit to the
data (LL = 268.35). Dose is defined as TR from Eq. 3.
Model over- and underpredicts incidence of VGE for all groups of
data.
|
|
Because PAN2 (or
PaN2) was estimated by using Eq. 1, it
was appropriate to determine whether variations in the
respiratory exchange ratio R affect the predictability of the
model. We added R as an additional parameter to the four-parameter
model and evaluated the model for values of R between 0.70 and 1.0. The
ability to describe the response variable is not affected by including
R as a parameter. The model is robust, since variations of R between 0.70 and 1.00 do not influence the LL value (251.70). Clearly, variations in R and, therefore, small changes in dissolved
N2 tissue fraction have no influence on the model.
 |
DISCUSSION |
Presence of Bubbles
We considered only the existence of bubbles and their relationship to
pressures of dissolved gases in the model. The model determines the
probability of bubble formation on the basis of total tension of
dissolved gases in tissue before decompression. However, the accuracy
of the Doppler detection is limited. Precordial Doppler detection
reflects the quantity of bubbles, but we do not know how to evaluate
the sensitivity of the device. Stationary bubbles spawned in the
microcirculation cannot be detected by Doppler-shift ultrasonography
(7) but may be detectable when dislodged by flexing the limb at the
time of Doppler detection (1). A free-gas phase, which is static or of
small volume (7) and outside of the limit of sensitivity of the
ultrasonic device, can give rise to false negatives (that is, no
bubbles are detected, although they are present).
Mechanistic Hypotheses
Tissues with higher dissolved N2 gas tissue tension than
ambient pressure facilitate bubble formation (5, 12). The generation of
bubbles from "gas micronuclei" through "nucleation
processes" (9, 16) is then followed by an initial explosive
bubble-growth phase (12) during the supersaturation. However, our
results indicate that dissolved N2 may not be the only gas
to initiate this explosive bubble-growth phase. This explosive growth
involves the immediate surroundings of the bubble and may recruit other dissolved gases in the tissue, e.g., CO2, O2,
water vapor, and even argon (1 kPa). The accelerated log logistic
survival model predicted that DCI (and presumably bubbles) may occur
when the altitude pressure is ~20 kPa, even though estimated
N2 pressure was zero in the 360-min compartment (3);
therefore, this finding suggests a metabolic gas participation in
bubble formation. After complete washout of dissolved N2 in
a tissue, the dissolved metabolic gases in the tissue would evolve from
solution as ambient pressure approaches a vacuum (3).
The initial explosive-growth phase precipitates a series of events.
Bubble size is inversely proportional to surface tension pressure, and
the driving force for diffusion of gas into a bubble increases as
surface tension pressure diminishes (12). Nitrogen tension in the
tissue becomes a driving force for diffusion, causing N2 to
diffuse from tissue to nascent bubble. Once molecules of N2
are captured inside the newly generated bubble, they are involved in
the N2 partial pressure of the bubble as an outward radial pressure. In contrast, pressure due to surface tension is an inward radial pressure that tends to reduce the bubble volume. Thus, in
modeling bubble growth, the surface tension pressure should be
subtracted from N2 dissolved tissue tension. Similarly,
tissue elastic recoil is also an inward radial pressure as well as
O2 ambient pressure; both quantities should then be
subtracted from the N2 dissolved tissue tension.
Underlying mechanisms of bubble growth suggest that surface tension
pressure and tissue elastic recoil are not involved in Pother. If Pother is not due to inward radial
elastic forces, it should then be caused by gas(es) in physical
solution in the tissue before the initial explosive-growth phase. The
positive sign of Pother unmasks the contribution of an
outward radial pressure due to this (these) dissolved gas(es).
Assuming that Pother is due to gas(es) previously dissolved
in tissues, it is questionable whether the tissue gas(es) tension could
follow various distributions with time. Indeed, an alternative to the
single-exponential tissue-gas exchange for N2 and to the constant second-term Pother of Eq. 4 has to be
examined. The number of plausible tissue types considered in the
analysis may, in fact, be more than one (18). It has been shown (in
dogs) that tissue isobaric gas exchange for 133Xe (21) is
better described by two or three exponential processes in series. The
exponential-series analysis (18) assigns one exponential term or
t1/2 for inert-gas washout for each tissue present
in the expression of dose. These models were applied to predict
probability of DCI in diving (11, 22), and it was found that the
prediction of DCI incidence was similar for both the series and
parallel arrangement of tissues (11). It is questionable how a detailed
description of the tissue gas exchange for N2 including another exponential term in lieu of Pother in Eq. 4
would predict the VGE outcome in the NASA hypobaric exposures.
Therefore, we tested (although analysis is not shown) an expression of
dose derived from a double-exponential gas exchange in a single tissue or a monoexponential gas exchange in a parallel arrangement of two
tissues, each tissue with a different exponential term (22). This dose
was then used in the logistic model. The addition of more parameters in
the model even further reduced the goodness of fit. In contrast to some
DCI data from hyperbaric exposures (11, 22), a monoexponential gas
exchange in a single tissue for N2, as described in our
analysis, better fitted the data of hypobaric exposures than a complex
gas-exchange kinetics with two exponential terms. The rationale behind
these observations is that Pother is not an additional
pressure due to N2, which would be disregarded by the
PtiN2(t) term of Eq. 4, and
that noninert gas(es) would assist N2 during the initial
explosive bubble-growth phase.
Clearly, two types of tissue gas exchange appear in the expression for
dose, TR', in the best fit four-parameter model. Our best predictor for
the total driving tension of the tissue ratio is made up of two
pressure terms, each with a different relation to time. The two types
of tissue gas exchange were 1) an elimination of dissolved
N2 exponentially related with time, as described by others
(5, 18); and 2) a gas tension in terms of Pother, which remains constant, presumably due to metabolic gases. Among all
dissolved gases in tissues, this exponential elimination appears to be
a characteristic of N2 tissue gas exchange.
The aforementioned mechanistic premises allow further insight into
properties of Pother in bubble formation. However, no
direct measurement could verify any postulate about Pother.
Our statistical analysis shows a correlation between Pother
and the model parameter b1, and thus a decrease in
the LL value may be due to an improvement in the model caused
by the addition of Pother in determining dose.
It is also unclear whether the magnitude for Pother
obtained in this analysis is a coincidence. The value of 143 mmHg (19.1 kPa) is approximately the tension (BTPS) of metabolic gases
in tissue or in mixed venous blood. This finding suggests that nearly all the dissolved gas, other than the N2 that remains in
physical solution in the tissue, has also been utilized to separate the gas phase.
The dissolved tissue tension of all gases involved in the bubble
growth, or driving tension, warrants a brief description. Figure
4 shows two dose-response curves of the
best fit four-parameter model corresponding to the two altitude
pressures of 30 and 45 kPa, respectively. As a result of a complete
denitrogenation
[PtiN2(t) = 0], the driving tension still available is ~19.1 kPa; Pother,
presumably because of metabolic gases, remains constant, whereas the
dissolved N2 tissue tension in the expression of dose
depends on the denitrogenation procedure. In contrast, without
preliminary denitrogenation, and according to our analysis, the total
driving tension that can potentially generate bubbles in tissues is
93.3 kPa; it is calculated by subtracting the arteriovenous
O2 difference (8 kPa) from the standard pressure (101.3 kPa). The pressure difference of 8 kPa is due to a phenomenon known as
the "oxygen window" (15) because metabolism lowers partial
O2 tension in tissues below the value in arterial blood.
The 95% confidence intervals were computed based on the propagation of
error formula (14). It is seen that the confidence intervals are
narrower in the case of 30 kPa than in the case of 45 kPa. The
confidence interval provides a range for the parametric values, but it
does not establish the accuracy of the estimate. Furthermore, the
larger the sample size, the narrower the confidence intervals (3).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Probability of VGE predicted by best model as function of dissolved
tissue tension of gases generating bubbles. Two isopressure isopleths
are displayed for 2 altitude pressures of 30 kPa (top curve)
and 45 kPa (bottom curve). Nonzero probability of VGE starts to
rise for a driving pressure of ~20 kPa. At altitude pressure of 30 kPa, without denitrogenation, model predicts occurrence of VGE with
probability 1 when a dissolved gas tissue tension is 100 kPa. The 95%
confidence interval is shown by shaded area.
|
|
Fractions of Gases
The transfer of gases into nascent bubbles is related to their
pressures in tissues at the end of the denitrogenation. The washout of
dissolved N2 in tissue depends on the denitrogenation; when
excess of dissolved N2 is removed from the tissue,
metabolic gases fraction is obliged to be larger in nascent bubbles
(13). The fraction of presumed metabolic gases was calculated for each of the 20 procedures as the ratio of the parameter estimate of Pother (equal to 19.1 kPa) to the estimated N2
dissolved tissue tension at the end of denitrogenation given by Eq. 2. The fraction-generating bubbles (for R = 0.82) ranged from 21 to 44%, whereas the balance N2 fraction ranged from 56 to
79%. The latter estimation applies to the initial explosive
bubble-growth phase; to estimate the fraction of metabolic gases that
diffuse in and out of the bubble, after this initial phase, it is
appropriate to use mathematical simulations of gas bubbles (13).
Furthermore, during the slower bubble growth, simulations showed that
the metabolic gases made up even larger fractions of the bubble because
of transients for CO2 and O2 (13).
The mechanistic role of metabolic gases in bubble formation appears to
be inversely proportional to the excess of dissolved N2 in
tissue; comparison of hypobaric and hyperbaric exposures indicates
significant difference. The Pother value derived from these
NASA hypobaric decompressions is higher than values from direct
measurements in diving experiments with guinea pigs breathing air or
gas mixtures (8); metabolic gases fraction in bubbles was ~10%, with
the balance of 90% due to inert gas. In human dives, there is a slight
chance that O2 could be 40% as effective as N2
in producing a risk of DCI (19). In hyperbaric conditions, dissolved
N2 tissue tensions and fractions are large, whereas metabolic tissue tensions and fractions remain constant. Therefore, the
fraction of inert gas that is likely to participate in the bubble-formation process should be greater in hyperbaric decompression than in hypobaric decompression. Moreover, a detailed model of tissue
gas exchange considered in terms of either a series or parallel
arrangement of tissues may provide a better fit to the data from diving
exposures.
Conclusions
Our statistical analysis of empirical data suggests a significant role
of gases other than N2 in bubble formation. First, the
additional parameter of tension Pother is attributed to
gases that are in physical solution in tissue at the end of the
denitrogenation. Second, this tension of dissolved gases remains
constant throughout the denitrogenation, whereas N2 tissue
exchange follows an elimination that exponentially decreases with time.
An exponential distribution in lieu of the Pother term used
in Eq. 4 would have impaired the model prediction. Finally,
third, the internal pressure exerted by gases other than N2
becomes an outward radial pressure of gas(es) in the bubble during the
initial explosive-growth phase. It appears that metabolic gases may
assist the initial explosive bubble-growth phase, as shown by our
analysis.
 |
ACKNOWLEDGEMENTS |
P. P. Foster performed this research at National Aeronautics and
Space Administration (NASA) Johnson Space Center as an External Postdoctoral Fellow of European Space Agency (8-10 rue
Mario-Nikis, 75738 Paris cedex 15; associated with Laboratoire de
Physiologie de l'Environnement, Faculté de Médecine Lyon
Grange-Blanche, 8 Ave. Rockefeller, 69373 Lyon cédex 08, France)
and as a visiting scientist through the Universities Space Research
Association, Division of Space Life Sciences, 3600 Bay Area Blvd.,
Houston, TX 77058. Research of R. S. Chhikara was partially supported
under NASA Grant NAG-9-802.
 |
FOOTNOTES |
Address for reprint requests: P. P. Foster, Life Sciences Research
Laboratories, Environmental Physiology Laboratory (SD3), NASA-Lyndon B. Johnson Space Center, Houston, TX 77058.
Received 4 October 1995; accepted in final form November 7, 1997.
 |
REFERENCES |
1.
Adams, J. D.,
R. M. Olson,
and
G. A. Dixon.
Use of the precordial bubble detector in altitude decompressions.
In: Proc. 1979 Aerospace Med. Assoc. Meeting Washington DC 1979, p. 260-261.
2.
Conkin, J., B. F. Edwards, J. M. Waligora, and D. J. Horrigan.
Empirical models for use in designing decompression for space
operations. NASA Tech. Memorandum 100456, 1987.
3.
Conkin, J.,
K. V. Kumar,
M. R. Powell,
P. P. Foster,
and
J. M. Waligora.
A probabilistic model of hypobaric decompression sickness based on 66 chamber tests.
Aviat. Space Environ. Med.
67:
176-183,
1996[Medline].
4.
Gerth, W. A.,
and
R. Vann.
Statistical bubble dynamics algorithms for assessment of altitude decompression sickness incidence.
In: Final Report, Contract No. F-336-90-D-0606, Task 0026, Dept. of Anesthesiology, F. G. Hall Hypo-Hyperbaric Center. Durham, NC: Duke Univ. Medical Center, 1994, p. 6-29.
5.
Hills, B. A.
Effects of decompression per se on nitrogen elimination.
J. Appl. Physiol.
45:
916-921,
1978[Abstract/Free Full Text].
6.
Hosmer, D. A.,
and
S. Lemeshow.
Introduction.
In: Applied Logistic Regression. New York: Wiley Interscience, 1989, p. 6-20.
7.
Kumar, K. V.,
J. M. Waligora,
and
M. R. Powell.
Epidemiology of decompression sickness under simulated space extravehicular activities.
Aviat. Space Environ. Med.
64:
1032-1039,
1993[Medline].
8.
Lillo, R. S.,
M. E. MacCallum,
and
J. M. Caldwell.
Intravascular bubble composition in guinea pigs: a possible explanation for differences in decompression risk among different gases.
Undersea Biomed. Res.
19:
375-386,
1992[Medline].
9.
Powell, M. R.,
J. M. Waligora,
and
K. V. Kumar.
Decompression gas phase formation in simulated null gravity.
In: 25th Int. Conf. on Environmental Systems San Diego SAE Technical Paper, 1995.
10.
Rahn, H.,
and
W. O. Fenn.
A Graphical Analysis of the Respiratory Gas Exchange. The O2-CO2 Diagram. Washington, DC: Am. Physiol. Soc., 1955.
11.
Tikuisis, P.,
R. Y. Nishi,
and
P. K. Weathersby.
Use of the maximum likelihood method in the analysis of chamber air dives.
Undersea Biomed. Res.
15:
301-313,
1988[Medline].
12.
Van Liew, H. D.,
and
M. E. Burkard.
Density of decompression bubbles and competition for gas among bubbles, tissue, and blood.
J. Appl. Physiol.
75:
2293-2301,
1993[Abstract/Free Full Text].
13.
Van Liew, H. D.,
and
M. E. Burkard.
Simulation of gas bubbles in hypobaric decompressions: roles of O2, CO2, and H2O.
Aviat. Space Environ. Med.
66:
50-55,
1995[Medline].
14.
Van Liew, H. D.,
J. Conkin,
and
M. E. Burkard.
Probabilistic model of altitude decompression sickness based on mechanistic premises.
J. Appl. Physiol.
76:
2726-2734,
1994[Abstract/Free Full Text].
15.
Van Liew, H. D.,
J. Conkin,
and
M. E. Burkard.
The oxygen window and decompression bubbles: estimates and significance.
Aviat. Space Environ. Med.
64:
859-865,
1993[Medline].
16.
Vann, R. D.
Exercise and circulation in the formation and growth of bubbles.
In: Supersaturation and Bubble Formation In Fluids and Organisms, edited by A. O. Brubakk,
B. B. Hemmingsen,
and G. Sundnes. Trondheim, Norway: Tapir, 1989, p. 235-263.
17.
Vann, R. D.
Likelihood analysis of decompression data using Haldane and bubble growth model.
In: Proc. 9th Int. Symp. on Underwater and Hyperbaric Physiology Undersea and Hyperbaric Medical Society Bethesda MD 1987., p. 165-181.
18.
Weathersby, P. K.,
E. E. P. Barnard,
L. D. Homer,
and
K. G. Mendenhall.
Stochastic description of inert gas exchange.
J. Appl. Physiol.
47:
1263-1269,
1979[Abstract/Free Full Text].
19.
Weathersby, P. K.,
B. L. Hart,
E. T. Flynn,
and
W. F. Walker.
Role of oxygen in the production of human decompression sickness.
J. Appl. Physiol.
63:
2380-2387,
1987[Abstract/Free Full Text].
20.
Weathersby, P. K.,
L. D. Homer,
and
E. T. Flynn.
On the likelihood of decompression sickness.
J. Appl. Physiol.
57:
815-825,
1984[Abstract/Free Full Text].
21.
Weathersby, P. K.,
K. G. Mendenhall,
E. E. P. Barnard,
L. D. Homer,
S. S. Survanshi,
and
F. Vieras.
Distribution of xenon gas exchange rates in dogs.
J. Appl. Physiol.
50:
1325-1336,
1981[Abstract/Free Full Text].
22.
Weathersby, P. K.,
S. S. Survanshi,
L. D. Homer,
B. L. Hart,
R. Y. Nishi,
E. T. Flynn,
and
M. E. Bradley.
Statistically Based Decompression Tables. I. Analysis of Standard Air Dives: 1950-1970. Bethesda, MD: Naval Medical Research Institute, 1985NMRI 85-16.
23.
Wilkinson, L. SYSTAT: the System for Statistics. Evanston,
IL: SYSTAT Inc., version 5.03, 1990, p. 342-387.
24.
Wolfram, S. MATHEMATICA: A System for Doing Mathematics by
Computer. Champaign, IL: Wolfram Research Inc., version 2.2, 1993.
JAP 84(3):1088-1095
0161-7567/98 $5.00
Copyright © 1998 the American Physiological Society